United States Backs Certiorari In Patent Dispute Over Generic Drug Labeling
WASHINGTON, D.C. — In a March 29 amicus curiae brief filed at the U.S. Supreme Court’s request, the U.S. government recommended that the high court grant a petition for certiorari in...To view the full article, register now.
Already a subscriber? Click here to view full article